Physician

Elena Maxim Kurland, MD

According to 2025 Medicare claims, Elena Kurland, MD (NPI: 1184120602) practices dermatology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1780137232; TIN: 391351587) and primary practice location at 47130-3669.

Kurland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,022 traditional Medicare patients, billed 5,556 HCPCS/CPT codes, and received $241,818 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,706 prescription claims across 608 beneficiaries totaling $1,493,438 in drug costs, led by Cuvitru (Immun Glob G(Igg)/Gly/Iga Ov50). Open Payments data shows 179 records totaling $6,495. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $978 to $1,493,438. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$121K$242K2022 Medicare payment: $33,264 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $177,650 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $241,818 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022209626$33,264
20238724,119$177,650
20241,0225,556$241,818

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$747K$1.5M2018 Drug cost: $978 (USD; Tot_Drug_Cst)2019 Drug cost: $35,629 (USD; Tot_Drug_Cst)2020 Drug cost: $38,986 (USD; Tot_Drug_Cst)2021 Drug cost: $169,010 (USD; Tot_Drug_Cst)2022 Drug cost: $53,539 (USD; Tot_Drug_Cst)2023 Drug cost: $984,465 (USD; Tot_Drug_Cst)2024 Drug cost: $1,493,438 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181116$978
201991227$35,629
2020129323$38,986
2021131337$169,010
2022159361$53,539
20234021,150$984,465
20246081,706$1,493,438

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more326451$88
11102Biopsy of related skin growth, first growth331378$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more501639$59
17000Destruction of precancer skin growth, 1 growth425556$33
17003Destruction of precancer skin growth, 2-14 growths3652,127$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CuvitruImmun Glob G(Igg)/Gly/Iga Ov5013364$461,870
Taltz AutoinjectorIxekizumab26728$176,154
Cosentyx Sensoready (2 Pens)Secukinumab16448$115,729
Dupixent SyringeDupilumab23644$87,460
RinvoqUpadacitinib13390$81,934

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.179$6,495UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Elena Maxim Kurland, MD?

Tedicare shows public-source Medicare data for Elena Maxim Kurland, MD (NPI 1184120602), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elena Maxim Kurland, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Elena Maxim Kurland, MD?

Elena Maxim Kurland, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1780137232) in the available physician profile data.

Does Elena Maxim Kurland, MD have Open Payments data?

Elena Maxim Kurland, MD has 179 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.